Log In
Print
BCIQ
Print
Print this Print this
 

Omidria (OMS302)

  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionCombination of ketorolac, an anti-inflammatory agent, and phenylephrine, a pupil dilating agent
Molecular Target Cyclooxygenases (COX) ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationCataract
Indication DetailsMaintain pupil dilation during cataract and other lens replacement surgery and reduce postoperative pain and irritation; Maintain pupil dilation during cataract and other lens replacement surgery and reduce postoperative pain and irritation in pediatric patients
Regulatory Designation

U.S. - Standard Review (Maintain pupil dilation during cataract and other lens replacement surgery and reduce postoperative pain and irritation);
EU - Standard Review (Maintain pupil dilation during cataract and other lens replacement surgery and reduce postoperative pain and irritation)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today